Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic drugs, highlighting substantial price markups by PBMs on medications for cancer, HIV and other conditions. The post Healthcare Leaders Support FTC’s…

Read More

Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success

Understanding how site augmentation services could be leveraged to overcome challenges is not the responsibility of one entity. The most creative and effective solutions arise from collaboration among all stakeholders — sponsors, CROs, service providers, and research sites. The post Bridging Clinical Research Gaps: How Site Augmentation Enhances Trial Success appeared first on MedCity News.

Read More

Reporting Checklist for Discrete Choice Experiments in Health

What are the key elements for reporting your objective, attributes, experimental design, survey design, data collection process, econometric analysis, and results? A paper by Ride et al. (2024) conducted a Delphi Panel expert elicitation survey to create the DIRECT checklist for discrete choice experiment (DCE) studies in health. The checklist is pasted below. https://link.springer.com/content/pdf/10.1007/s40273-024-01431-6 If…

Read More